ClaimCompass

You found the right place. We’ll read the letter, explain it in plain English, and tell you what to do next.

Free in about 30 seconds →
CO-55Denial code

You found the right place.

CO-55 Denial Code — Experimental or Investigational — What It Means and How to Appeal

CO-55 is one of the most aggressively issued and most successfully appealed denial codes. Insurers' experimental criteria routinely lag behind published medical evidence — and appeals built on peer-reviewed science win at high rates.

80
Appeal Viability Score High when peer-reviewed evidence and medical society guidelines support the treatment
Analyze My CO-55 Denial — Free →

No account needed · Results in about 30 seconds · Free to start

CO-55 Is One of the Most Overturnable Denial Codes

When peer-reviewed evidence and medical society guidelines support the treatment, CO-55 appeals reverse at high rates.

85–100Published trials and society guidelines contradict the insurer's experimental label
65–84Off-label use listed in a recognized compendium — coverage should apply
40–64Newer therapy with limited published evidence — external review is the stronger path

CO-55 Denial Code Description — What It Means in Medical Billing

The official CO-55 denial code description:

"Procedure/treatment has not been deemed 'proven effective' by the payer."

CO-55 means the insurer's technology assessment or clinical criteria classified your treatment as experimental or investigational. This classification is the insurer's opinion — not a legal or medical fact. Insurers maintain proprietary clinical criteria (often from third-party vendors like Hayes or ECRI) that frequently lag behind peer-reviewed medical evidence by years.

The distinction that matters for your appeal: a treatment is experimental when it lacks substantial scientific evidence. A treatment is established when peer-reviewed trials, medical society guidelines, and clinical experience support it. Many CO-55 denials are issued for treatments that the medical community considers standard of care.

CO-55 Denial Reason — Why This Denial Happens and How to Overturn It

1

Insurer criteria lag behind published evidence

Technology assessment vendors update their criteria infrequently. A treatment with five years of randomized controlled trial data and medical society endorsement may still be classified as experimental in an insurer's criteria if the criteria weren't updated after the evidence emerged. Your appeal should cite the specific publications and guidelines the insurer's criteria missed.

2

Off-label drug use classified as investigational

Off-label prescribing is common and legal — it is not the same as experimental use. If the drug is FDA-approved and appears in a recognized compendium (DrugDex, AHFS) for your diagnosis, federal law requires most plans to cover it. The CO-55 denial is improper.

3

Criteria applied are more restrictive than Medicare coverage

If Medicare covers the treatment under a National or Local Coverage Determination (NCD/LCD), that is strong evidence the treatment is not experimental. Appeals arguing that the insurer's criteria are more restrictive than Medicare's — without clinical justification for the difference — are persuasive to external reviewers.

CO-55 Denial Code Solution — Step-by-Step Resolution

1

Obtain the insurer's criteria

Request a copy of the specific clinical criteria used to deny your claim. This is your right under ERISA and ACA regulations. Identify exactly which criterion your treatment failed and what evidence was (and wasn't) considered.

2

Build a clinical evidence file

Gather: peer-reviewed publications supporting the treatment for your diagnosis, relevant clinical practice guidelines from specialty medical societies (ASCO, AHA, AAN, etc.), FDA approvals or clearances, Medicare NCD/LCD coverage, and compendium listings for drug cases.

3

Request an expedited peer-to-peer review

Your treating physician should request a peer-to-peer review with the insurer's medical director immediately. Bring the published evidence. Many CO-55 denials are reversed at peer-to-peer when the treating physician presents clinical trial data directly.

4

File for external independent review

External review overturns CO-55 denials at some of the highest rates of any denial type. IROs evaluate clinical evidence independently and are not bound by the insurer's proprietary criteria.

CO-55 Denied? Get Your Free Analysis.

Start My Free Analysis →

Free to analyze · $39 complete appeal · No subscription

Still looking

You’re in the right place.

Upload the letter. We’ll tell you what it means — free.

No account. About 30 seconds. Plain English, then a clear next step.

No account. File deleted after your score — and after letter delivery if you purchase.

You don’t have to figure this out alone.

Analyze my letter — free